Swant Inc - Company Review
Swant Inc - Company ReviewSummary
Swant Inc (Swant) is a drug development company that develops antibodies, neurotransmitters and respective antigens. The company offers products which include antibodies against Ca2+ binding proteins, antibodies against Ca2+ channels, Ca2+ exchangers and Ca2+ pumps. It provides antibodies against insulin-like growth factors, antibodies against neurotransmitters, and antibodies against components of the renin-angiotensin system, miscellaneous antibodies, and purified proteins. Swant also offers procedure for the immunolabelling of sections with rabbit antisera, immunolabelling of sections with goat antisera, and mmunolabelling of sections with mouse monoclonal antibodies. The company's products are used in selective staining of various types of cancers. It provides packaging and shipping services. Swant is headquartered in Marly, Switzerland.
This comprehensive company report of Swant Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.